Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8-Reference-Cited by-同舟云学术

Prognostic gene mutations and distinct gene- and microRNA-expression signatures in acute myeloid leukemia with a sole trisomy 8

Published:2014-03-21 Issue:8 Volume:28 Page:1754-1758
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Becker H, ,Maharry K,Mrózek K,Volinia S,Eisfeld A-K,Radmacher M D,Kohlschmidt J,Metzeler K H,Schwind S,Whitman S P,Mendler J H,Wu Y-Z,Nicolet D,Paschka P,Powell B L,Carter T H,Wetzler M,Kolitz J E,Carroll A J,Baer M R,Caligiuri M A,Stone R M,Marcucci G,Bloomfield C D

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2014114.pdf

Reference17 articles.

1. Mrózek K, Heerema NA, Bloomfield CD . Cytogenetics in acute leukemia. Blood Rev 2004; 18: 115–136.

2. Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010; 115: 453–474.

3. Rocquain J, Carbuccia N, Trouplin V, Raynaud S, Murati A, Nezri M et al. Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias. BMC Cancer 2010; 10: 401.

4. Caramazza D, Lasho TL, Finke CM, Gangat N, Dingli D, Knudson RA et al. IDH mutations and trisomy 8 in myelodysplastic syndromes and acute myeloid leukemia [letter]. Leukemia 2010; 24: 2120–2122.

5. Alpermann T, Haferlach C, Eder C, Kohlmann A, Kern W, Haferlach T et al. Sole trisomy 8 in AML: concomitant molecular markers, stability of genetic patterns and impact on outcome. Blood 2012; 120, (abstract 2503).

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Distinct karyotypic and mutational landscape in trisomy AML;British Journal of Haematology;2023-12-06

2. The presence of additional cytogenetic aberrations in chronic myeloid leukemia cells at the time of diagnosis or their appearance on tyrosine kinase inhibitor therapy predicts the imatinib treatment failure;Leukemia Research;2023-09

3. Molecular genetic and clinical characterization of acute myeloid leukemia with trisomy 8 as the sole chromosome abnormality;Hematology;2022-05-12

4. Autoimmune and inflammatory manifestations associated with acute myeloid leukemia with Trisomy 8—Case series and review of the literature;European Journal of Haematology;2021-12-21

5. Risk Stratification, Measurable Residual Disease, and Outcomes of AML Patients with a Trisomy 8 Undergoing Allogeneic Hematopoietic Stem Cell Transplantation;Cancers;2021-11-13